Product
Icosapent ethyl
Aliases
Vascepa
3 clinical trials
6 indications
Indication
Alzheimer's DiseaseIndication
COVID-19Indication
AtherosclerosisIndication
Cardiovascular DiseasesIndication
Upper Respiratory Tract InfectionsIndication
Aortic Valve StenosisClinical trial
Impact of Icosapent Ethyl on Alzheimers Disease Biomarkers in Preclinical AdultsStatus: Completed, Estimated PCD: 2023-09-29
Clinical trial
A Pragmatic Randomized Trial of Icosapent Ethyl for High-Cardiovascular Risk Adults (MITIGATE)Status: Terminated, Estimated PCD: 2022-12-15
Clinical trial
IcoSApent ethyL to Slow Down Aortic VAlve Stenosis proGrEssionStatus: Recruiting, Estimated PCD: 2026-07-01